Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Quarterly results
Appointed director
CC transcript

ZYMOGENETICS INC (ZGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2010 8-K Form 8-K - Current report
05/04/2010 8-K Quarterly results
Docs: "ZymoGenetics Reports First Quarter 2010 Financial Results - Results show improved financial performance and strengthened financial position - - Pipeline advancement and increased RECOTHROM market penetration highlighted -"
02/11/2010 8-K Form 8-K - Current report
11/05/2009 8-K Quarterly results
Docs: "ZymoGenetics Reports Third Quarter 2009 Financial Results - Increased revenues and reduced expenses drive substantial improvement in quarterly net loss - - RECOTHROM sales increase to $8.5 million compared to $1.8 million a year earlier -"
05/05/2009 8-K Form 8-K -- Current report
02/11/2009 8-K Quarterly results
Docs: "ZymoGenetics Reports Fourth Quarter and Year End 2008 Financial Results - Increased product sales, license and collaboration revenues - - Financial position strengthened through PEG-Interferon lambda collaboration -"
11/04/2008 8-K Quarterly results
Docs: "ZymoGenetics Reports Third Quarter 2008 Financial Results"
08/05/2008 8-K Quarterly results
Docs: "ZymoGenetics Reports Second Quarter 2008 Financial Results - RECOTHROM 20,000-IU vial and spray kit approved by FDA - - $100 million funding commitment secured from Deerfield Management -"
05/06/2008 8-K Quarterly results
Docs: "ZymoGenetics Reports First Quarter 2008 Financial Results January FDA Approval of RECOTHROM™ and Launch Highlights"
02/13/2008 8-K Quarterly results
Docs: "ZymoGenetics Reports Fourth Quarter and Year End 2007 Financial Results -- Year Highlighted by Expanded Commercial Operations and Pipeline Advancement --"
08/02/2007 8-K Quarterly results
Docs: "ZymoGenetics Reports Second Quarter 2007 Financial Results -Partnership with Bayer augments internal preparations for rThrombin launch-"
05/03/2007 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZymoGenetics Reports First Quarter 2007 Financial Results"
02/20/2007 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZYMOGENETICS REPORTS FOURTH QUARTER AND YEAR END 2006 FINANCIAL RESULTS"
11/01/2006 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZYMOGENETICS REPORTS THIRD QUARTER 2006 FINANCIAL RESULTS"
08/04/2006 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZYMOGENETICS REPORTS SECOND QUARTER 2006 FINANCIAL RESULTS"
05/09/2006 8-K Quarterly results
Docs: "ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.",
"ZYMOGENETICS REPORTS FIRST QUARTER 2006 FINANCIAL RESULTS -"
02/10/2006 8-K Quarterly results, Appointed a new director
Docs: "Telephone Number, Including Area Code)",
"ZYMOGENETICS REPORTS FOURTH QUARTER AND YEAR END 2005 FINANCIAL RESULTS -"
11/03/2005 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZYMOGENETICS REPORTS THIRD QUARTER 2005 FINANCIAL RESULTS"
08/02/2005 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZymoGenetics Reports Second Quarter 2005 Financial Results"
05/10/2005 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZymoGenetics Reports First Quarter 2005 Financial Results; Momentum Continues with Three Product Candidates in Clinical Development"
02/11/2005 8-K Quarterly results
Docs: "Telephone Number, Including Area Code)",
"ZymoGenetics Reports Fourth Quarter and Year End 2004 Financial Results; Highlights Include Pipeline Advancement, Strategic Transactions and Stronger Financial Position"
11/09/2004 8-K Quarterly results, Appointed a new director
Docs: "Telephone Number, Including Area Code)",
"ZymoGenetics Reports Third Quarter 2004 Financial Results; Major Business Development Initiatives Enable Greater Focus on Genomics-Based Pipeline"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy